Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
- PMID: 29489473
- PMCID: PMC5876122
- DOI: 10.1097/CEJ.0000000000000428
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
Abstract
To facilitate regionally specific liver cancer prevention and control, this study estimates the fraction of hepatocellular carcinoma (HCC) cases attributable to five major liver cancer risk factors by geographic region. Prevalence estimates of major HCC risk factors, including chronic infection with hepatitis B and hepatitis C, alcohol drinking, tobacco smoking, obesity, and diabetes, were extracted for each country from the literature, along with recent incidence and risk estimate data, to calculate regionally specific population attributable fractions. Overall, 44% of HCC cases worldwide were attributable to chronic hepatitis B infection, with the majority of cases occurring in Asia. Hepatitis C was responsible for 21% of cases. Lifestyle risk factors such as alcohol drinking and obesity were responsible for a larger percentage of cases in North America and Western, Central, and Eastern Europe. In addition, strong sex disparities were observed when looking at lifestyle risk factors, particularly tobacco smoking, in Asia and Africa. Prominent risk factors for HCC vary depending on the region. Our findings provide useful data for developing regionally specific guidelines for liver cancer prevention and control worldwide.
Conflict of interest statement
Conflicts of interest: We have no conflicts of interests to declare.
Figures
References
-
- American Cancer Society. [Accessed August 8th];Liver cancer risk factors. 2016 http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-risk....
-
- Bedwani R, El-Khwsky F, El-Shazly M, Seif HA, Zaki A, Renganathan E, et al. Hepatitis viruses, schistosomal infection and liver cancer in Egypt. Int J Cancer. 1996;68:688–9. - PubMed
-
- Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol 2017 - PubMed
-
- Bosetti C, Franchi M, Nicotra F, Asciutto R, Merlino L, La Vecchia C, et al. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases. Pharmacoepidemiol Drug Saf. 2015;24:771–8. - PubMed
-
- Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48:2137–45. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
